Advertisement
Screener

ALPHATEC HOLDINGS, INC. (ATEC) Business Acquisition, Pro Forma Revenue

3.3 / 5 stars · 52/80 Roast Me

ALPHATEC HOLDINGS, INC. Business Acquisition, Pro Forma Revenue

ALPHATEC HOLDINGS, INC. (ATEC) reported Business Acquisition, Pro Forma Revenue of $91.69 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-29.

Discontinued › Income Statement › Other Income

us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2019-03-29

  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2018-12-31 was $25.32M, a 3.99% decline year-over-year.
  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2018-09-30 was $23.00M, a 0.65% decline year-over-year.
  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2018-06-30 was $22.04M, a 9.80% decline year-over-year.
  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma revenue for the quarter ending 2018-03-31 was $21.34M, a 23.87% decline year-over-year.
  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2018 was $91.69M, a 10.09% decline from fiscal 2017.
  • ALPHATEC HOLDINGS, INC. business acquisition, pro forma revenue for fiscal 2017 was $101.98M.
Period endBusiness Acquisition, Pro Forma Revenue 3 monthBusiness Acquisition, Pro Forma Revenue 6 monthBusiness Acquisition, Pro Forma Revenue 9 monthBusiness Acquisition, Pro Forma Revenue 12 month
2018-12-31$25.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$48.32M
derived: sum of 2 quarters · filed 2019-03-29
$70.36M
derived: sum of 3 quarters · filed 2019-03-29
$91.69M
10-K · filed 2019-03-29
2018-09-30$23.00M
10-Q · filed 2018-11-09
$45.04M
derived: sum of 2 quarters · filed 2018-11-09
$66.38M
10-Q · filed 2018-11-09
$92.75M
derived: sum of 4 quarters · filed 2019-03-29
2018-06-30$22.04M
10-Q · filed 2018-08-03
$43.38M
10-Q · filed 2018-08-03
$69.75M
derived: sum of 3 quarters · filed 2019-03-29
$92.90M
derived: sum of 4 quarters · filed 2019-03-29
2018-03-31$21.34M
10-Q · filed 2018-05-11
$47.70M
derived: sum of 2 quarters · filed 2019-03-29
$70.86M
derived: sum of 3 quarters · filed 2019-03-29
$95.29M
derived: sum of 4 quarters · filed 2019-03-29
2017-12-31$26.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$49.52M
derived: sum of 2 quarters · filed 2019-03-29
$73.96M
derived: sum of 3 quarters · filed 2019-03-29
$101.98M
10-K · filed 2019-03-29
2017-09-30$23.15M
10-Q · filed 2018-11-09
$47.59M
derived: sum of 2 quarters · filed 2018-11-09
$75.61M
10-Q · filed 2018-11-09
2017-06-30$24.44M
10-Q · filed 2018-08-03
$52.46M
10-Q · filed 2018-08-03
2017-03-31$28.02M
10-Q · filed 2018-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
NovoCure Ltd (NVCR)$1.886B-11.87
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66